Now study shows weight-loss jabs might interfere with medical imaging

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestylePeople taking Ozempic and Wegovy might suffer unusual side effects (PA Archive)GLP-1 weight-loss drugs, including Ozempic and Wegovy, may interfere with medical imaging, potentially leading to misinterpretations. Researchers from Alliance Medical observed abnormal patterns of FDG uptake in oncologic PET-CT scans of patients taking these medications. Such misinterpretations could result in unnecessary diagnostic tests, incorrect cancer staging, and delays in vital treatment. Dr. Peter Strouhal, Medical Director at Alliance Medical, noted the increasing prevalence of these altered patterns and the absence of national or international guidance in the UK. Imaging professionals are advised to meticulously document patients’ medication history to prevent misdiagnosis and ensure appropriate care. In fullNew ‘unusual’ side effect of weight-loss drugs becoming more common, research suggestsThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

Raccontata dahuffpost.comindependent.co.uk